Budapest, Hungary

Maria Sz Sarkozi


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Sz Sarkozi: Innovator in Biologically Active Polypeptides

Introduction

Maria Sz Sarkozi is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of biochemistry, particularly in the preparation of biologically active polypeptides. Her innovative work has implications for therapeutic applications, showcasing her expertise and dedication to advancing scientific knowledge.

Latest Patents

Maria Sz Sarkozi holds a patent for a process related to the preparation of biologically active polypeptides. The invention focuses on utilizing the active-ester technique to create polypeptides containing the aspartyl group, specifically an aspartyl-glycine moiety. This method allows for the preparation of human adrenocorticotropic hormone and its fragments, which are valuable substances with therapeutic activity. The patent outlines a detailed process involving the pentafluorophenol method, where the carboxy group of the acylating component is activated to facilitate the coupling reaction with blocked peptides.

Career Highlights

Maria Sz Sarkozi is associated with Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company in Hungary. Her work at this institution has allowed her to collaborate with other experts in the field, contributing to advancements in biochemistry and pharmacology.

Collaborations

Some of her notable coworkers include Lajos Kisfaludy and Miklos Low, who have worked alongside her in various research projects. Their combined expertise has fostered an environment of innovation and discovery.

Conclusion

Maria Sz Sarkozi's contributions to the field of biologically active polypeptides highlight her role as a significant inventor. Her patented process not only advances scientific understanding but also has the potential to impact therapeutic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…